INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT
Date: February 15-16, 2007
- 2/15/07: 2:30 PM – 9:30 PM (Estimated)
- 2/16/07: 8:30 AM – 5:00 PM (Estimated)
- Sheraton Gateway Hotel –
San Francisco International Airport
600 Airport Boulevard
Burlingame, CA 94010
Tel: (650) 340-8500
- Call to Order.
- Pledge of Allegiance.
- Roll Call.
[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]
- Approval of minutes from December 7, 2006 ICOC meeting.
- Chairman’s Report.
- President’s Report.
- Consideration of recommendation from Grants Review Working Group to disclose working group members’ conflicts of interest for individual applications.
- Consideration Grants Working Group’s recommendations regarding SEED Grant applications.
a. Ranked List of SEED Grant Applications
b. Final Conflict of Interest List for SEED Grants
- Discussion of confidential intellectual property or work product and prepublication, confidential scientific research or data relating to SEED Grant applications (Health & Safety Code 125290.30(d)(3)(B) and (C)).
- Public report of any action taken, if necessary, during closed session.
- Continuation of consideration of Grants Review Working Group’s recommendations regarding SEED Grant applications.
- Consideration of naming initial SEED grant round in honor of Dr. Leon Thal.
a. Pending Litigation (Government Code section 11126, subdivision (e)): (1) People’s Advocate v. Independent
Citizens’ Oversight Committee, First District Court of Appeal, Case No. A114282 and California Family
Bioethics Council v. California Institute for Regenerative Medicine, First District Court of Appeal, Case No.
A114195; (2) Mary Scott Doe v. Robert Klein, et al., U.S. Court of Appeals for the Ninth Circuit, Case No.
06-55387; and (3) National Tax Limitation Foundation v. Westly, Sacramento Court Superior Court, Case
b. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section
- Consideration of appointment of new scientific members and new alternate scientific members of the Grants Review Working Group.
- Consideration of report and potential actions from public session of Grants Review Working Group meeting of January 8, 2007, including:
a. Recommendation that the ICOC amend the Grants Review Working Group bylaws to allow the Chair of the
working group to designate a scientific member to serve as alternate Chairperson in the Chair’s absence
during scientific review.
b. Makes no recommendation regarding designation of an ICOC patient advocate member of the working
group by the Vice-Chair to serve as alternate Vice-Chairperson in his or her absence.
c. Makes no recommendation regarding designation of other patient advocate members of the ICOC to
serve as alternates in the absence of any of the ICOC patient advocate members of the Grants Review
- Consideration of amendment to Conflict of Interest Policy for the Grants Review Working Group to clarify applicability to specialist members assisting the working group.
- Consideration of report from Presidential Search Subcommittee.
- Consideration of report from Legislative Subcommittee on state and federal legislation and related topics.
a. H.R. 3
b. S. 5
- Consideration of creation of International Subcommittee including composition of the subcommittee and its mission.
- Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.
THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.
The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at (415) 396-9100 no later than the day prior to the meeting.
Questions or requests for additional information prior to the Scientific and Medical Research Funding Working Group meeting may be referred to Pat Beaupre Becker at the California Institute for Regenerative Medicine at email@example.com or (415) 396-9105.
This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.